Phase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
28 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of South Alabama
Mobile, Alabama, United States
- Marin Cancer Care
Greenbrae, California, United States
- St. Joseph'S/candler Health System
Savannah, Georgia, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Carle Cancer Center
Urbana, Illinois, United States
- Indiana University
Indianapolis, Indiana, United States
- Siouxland Hematology Oncology Associates
Sioux City, Iowa, United States
- Ochsner Cancer Institute
New Orleans, Louisiana, United States
- Greater Baltimore Medical Center
Baltimore, Maryland, United States
- Tufts Medical Center
Boston, Massachusetts, United States
- St. Joseph Mercy Health System
Ann Arbor, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Metro Mn Ccop
Saint Louis Park, Minnesota, United States
- Missouri Valley Cancer Consortium
Omaha, Nebraska, United States
- Montefiore Medical Center
The Bronx, New York, United States
- Aultman Hospital
Canton, Ohio, United States
- University Hospitals Case Medical Center
Cleveland, Ohio, United States
- Toledo Community Oncology Program
Toledo, Ohio, United States
- Geisinger Medical Center
Danville, Pennsylvania, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- Reading Hospital
West Reading, Pennsylvania, United States
- Susquehanna Health Cancer Center
Williamsport, Pennsylvania, United States
- University of Virginia
Charlottesburg, Virginia, United States
- Charleston Area Medical Center (camc)
Charleston, West Virginia, United States
- Gundersen Health System
La Crosse, Wisconsin, United States
- Dean Clinic
Madison, Wisconsin, United States
- Prohealth Care, Inc.
Waukesha, Wisconsin, United States
- Aurora Health Care
Wauwatosa, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2013
- Primary completion
- 30 Apr 2016
- Completion
- 31 Aug 2016
- Last update posted
- 5 May 2017
- Registered enrollment
- 32
- Registry id
- NCT01889797
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.